代谢作为系统性红斑狼疮发病机制的关键调控因素
本文综述了系统性红斑狼疮(SLE)中代谢改变的研究进展。文章从免疫代谢角度阐述不同免疫细胞亚群的代谢需求差异,指出代谢变化既可能由炎症引起,也可能参与自身免疫发病机制,并讨论了代谢组学在发现新型细胞免疫疗法和疾病生物标志物方面的潜力。
要点
- 静息淋巴细胞通过氧化磷酸化和脂肪酸氧化供能,活化淋巴细胞快速转向糖酵解途径。
- SLE中代谢改变既可能是炎症的结果,也可能参与自身免疫发病机制。
- 代谢组学有望加速发现新型细胞免疫疗法和疾病生物标志物。
核心结论
- 代谢在自身免疫疾病中起关键作用,SLE的代谢改变既可能源于炎症,也可能参与发病机制。
研究设计与样本
- 本文为综述,回顾SLE中代谢改变的相关研究并讨论代谢组学的应用潜力。
主要发现
- 不同免疫细胞亚群有独特的代谢需求与功能,代谢重编程对不同细胞亚群产生不同影响。
- 静息淋巴细胞通过氧化磷酸化(OXPHOS)和脂肪酸氧化(FAO)供能,活化淋巴细胞快速转向糖酵解途径。
- SLE临床表现异质,其精确病理生理机制在很大程度上仍不清楚。
临床怎么用
- 可关注代谢组学作为发现SLE新型生物标志物和细胞免疫疗法研究方向的价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In the middle of the 20th century, biologists focused on investigating the mechanism of gene regulation and signal transduction in cells, which led to the concept that metabolites were products of gene expression and signal transduction pathways. In the 1920s, the importance of cellular metabolism was shown in the Warburg effect, in which cancer cells are characterized by a mitochondrial defect that shifts towards aerobic glycolysis. Recently, it is accepted that each organ and cell subset needs specific metabolic conditions and metabolic regulatory systems. Immunometabolism is a relatively new field of metabolism studies. The immune system consists of various cell subsets that have unique requirements and functions. The metabolic reprogramming in each immune cell causes different effects on different cell subsets. For example, resting lymphocytes generate energy through oxidative phosphorylation (OXPHOS) and fatty acid oxidation (FAO), whereas activated lymphocytes rapidly shift to the glycolytic pathway. A detailed understanding of metabolic regulation has progressed rapidly, especially in T cells during their differentiation from naïve to effector T cells. Metabolism is now considered to play a key role in autoimmune diseases. Metabolic changes in autoimmune diseases might be due to inflammation as well as being involved in autoimmune pathogenesis. Systemic lupus erythematosus (SLE) is an autoimmune disease with heterogenous clinical presentations whose precise pathophysiological mechanism is largely unknown. In this report, we review the altered metabolism in SLE and discuss the potential of metabolomics for accelerating the discovery of novel cellular autoimmune therapies and novel disease biomarkers.
引用
- Takeshima Y, Iwasaki Y, Fujio K, et al. Metabolism as a key regulator in the pathogenesis of systemic lupus erythematosus. Semin Arthritis Rheum. 2019. PMID: 31056210. doi:10.1016/j.semarthrit.2019.04.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。